Telix Pharmaceuticals Limited (TLPPF)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,664	5,098	2,224	1,563	1,606	818
Market Cap Growth	129.18%	129.18%	42.30%	-2.70%	96.45%	196.48%
Enterprise Value	5,580	5,038	2,144	1,482	1,572	801
Last Close Price	16.50	14.97	6.88	4.72	5.68	3.00
PE Ratio	183.35	165.02	626.21	-	-	-
PS Ratio	11.69	10.52	6.49	14.37	290.85	203.33
PB Ratio	16.11	14.50	21.91	28.75	1023.78	13.41
P/TBV Ratio	60.18	54.17	83.14	109.40	-	53.46
P/FCF Ratio	642.40	578.16	229.72	-	-	619.12
P/OCF Ratio	212.71	191.44	136.63	-	-	540.78
EV/Sales Ratio	10.96	10.39	6.26	13.62	284.54	199.24
EV/EBITDA Ratio	95.44	92.95	55.00	-	-	-
EV/EBIT Ratio	104.78	99.41	60.60	-	-	-
EV/FCF Ratio	632.89	571.37	221.37	-	-	606.68
Debt / Equity Ratio	1.02	1.02	0.12	0.13	1.18	0.03
Debt / EBITDA Ratio	6.47	6.47	0.30	-	-	-
Debt / FCF Ratio	40.81	40.81	1.23	-	-	1.29
Asset Turnover	0.82	0.82	1.52	0.88	0.06	0.04
Inventory Turnover	10.79	10.79	15.36	10.92	1.25	3.45
Quick Ratio	2.60	2.60	1.18	1.90	1.13	4.62
Current Ratio	2.78	2.78	1.41	2.03	1.25	4.69
Return on Equity (ROE)	13.92%	13.92%	4.55%	-253.34%	-198.36%	-60.21%
Return on Assets (ROA)	5.33%	5.33%	9.81%	-25.37%	-37.95%	-23.64%
Return on Capital (ROIC)	7.78%	7.78%	25.26%	-97.35%	-118.20%	-40.13%
Return on Capital Employed (ROCE)	6.90%	6.90%	21.50%	-	-	-
Earnings Yield	0.55%	0.61%	0.16%	-4.53%	-3.64%	-4.23%
FCF Yield	0.16%	0.17%	0.43%	-3.09%	-2.75%	0.16%
Buyback Yield / Dilution	-6.64%	-6.64%	-4.21%	-10.08%	-9.69%	-10.21%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.